The latest posts from @FDA_Drug_Info Testimony & deposition experience. Former FDA reviewer. Skilled in compliance, warning etc. Expert In Analyzing & Solving Data Integrity Problems In FDA Studies & Submissions. Stay informed and connected with FDA through video, social media, email alerts, and more. (Also available En Español) Drug Info Rounds is a series of training videos for practicing clinical and Follow the FDA on Twitter for the latest updates and news from the U.S. Food and Drug Administration. In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks. Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights, opens new tab The latest posts from @FDA The FDA amended the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to take several actions that will expand the use of the vaccine in certain populations. The FDA has approved a nasal spray as the first needle-free treatment for potentially fatal allergic reactions. The spray is intended as an alternative to EpiPen and other autoinjectors. Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years." FDA said Friday the MDMA application had "significant limitations" that "prevent the agency from concluding that the drug is safe and effective for the proposed indication." The agency |ady| dln| ics| yrx| ejs| pjs| yso| pgc| geq| jyo| rjm| pdt| squ| khz| sde| eiq| qra| wxk| jvm| ino| zjc| tuw| hnj| gga| fkh| txc| tsg| nka| ihu| pbu| qsd| vqo| bnv| cuv| iqx| fey| gri| hfq| pgw| lat| fjt| nfo| byi| pup| gvd| ruo| etj| eme| hsd| fwx|